Radiation Therapy Using Gold Markers in Treating Women With Early-Stage Breast Cancer

Recruiting in Palo Alto (17 mi)

Overseen byBruce G. Haffty, MD

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase 1

Waitlist Available

Sponsor: University of Medicine and Dentistry of New Jersey

No Placebo Group

Trial Summary

What is the purpose of this trial?

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Placing gold markers in the area where the tumor was removed may help doctors better direct radiation therapy and help reduce the risk of cancer recurrence. PURPOSE: This phase I trial is studying how well radiation therapy using gold markers works in treating women with early-stage breast cancer.

Eligibility Criteria

Inclusion Criteria

AJCC stage 0, I, or II (Tis, T1N0, or T2N0) disease with a lesion ≤ 3 cm treated with lumpectomy and either sentinel node biopsy or axillary dissection (if invasive carcinoma is present)

Unifocal breast cancer (i.e., single focus that can be encompassed by one lumpectomy)

Underwent or plan to undergo lumpectomy with placement of gold fiducial markers (markers placed concurrently with the surgery or on a later date)

See 6 more